Martina Sluga-O’Callaghan

Articles by Martina Sluga-O’Callaghan

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
April 18th 2022

Trending on CancerNetwork

KITE-753 Trials in R/R DLBCL Placed on Partial Clinical Hold for ICANS

AI-Measured Tumor Volume on PSMA PET-CT Linked With Survival in Prostate Cancer

How Could Rocbrutinib Plus R-CHOP Reshape Frontline Non-GCB DLBCL Treatment?

Managing FLOT Toxicity With Dose Reductions in Gastroesophageal Cancer

Expanding Access to Advanced Radiation Services Across a Network